TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Genomic Profiling of Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer after Progression on First-line Osimertinib: Phase II ORCHARD Study.

Helena A Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.